Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-01-26
1983-08-09
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
504 48, A61K 3117
Patent
active
043978681
ABSTRACT:
Methods of treating atherosclerosis with trisubstituted ureas, compositions thereof and processes for their preparation.
REFERENCES:
patent: 4011340 (1977-03-01), Nadelson
Chemical Abstracts, 85:20887c (1976) [Ger. ols 2,543,888, Yamada et al., 4/8/76].
Chemical Abstracts, 94:116002x and 94:116003y (1981) [Japan Kokai 80,160,707 and 80,160,705 12/13/80].
Chemical Abstracts, 95:114899s (1981) [Japan Kokai 81,32,447 4/1/81].
American Cyanamid Company
Richards J. W.
Schwartz Richard A.
LandOfFree
Method of treating atherosclerosis with trisubstituted ureas does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating atherosclerosis with trisubstituted ureas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating atherosclerosis with trisubstituted ureas will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-587036